Join us Dec. 1-3 in Nashville for the Digiday Programmatic Marketing Summit
Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
The case for and against AI token capping
Apple is placing strict limits on its staffers’ AI token consumption. Should the marketing sector take a similar path?
Reddit dangles seasonal ad credits but advertisers still want better proof it works all year round
Q4 credits may bring advertisers to Reddit, but concerns about measurement and its ad capabilities make it harder to secure year-round spend.
Amid a difficult transitional year, The Trade Desk posts a rare quarterly revenue decline
The Trade Desk’s Jeff Green hints at potential M&A, while rival DSP Viant buys Waymark.